In a market dominated by pharma giants and complex pump systems, Valeritas made a radical bet: one device, one form factor, zero complexity. With $355M in funding, they're not just selling a product—they're selling simplicity to a market desperate for it.

"They're not building a better pump—they're building the only device you'll ever need. That's the difference between iteration and revolution."

The tech stack reveals their priorities: jQuery, Bootstrap, Google Analytics. No React, no modern frameworks, no aggressive tracking. Even their payment processor is basic. They're not optimizing for conversion funnels—they're optimizing for clinical adoption. The $355M funding suggests they're playing a long game: building manufacturing, regulatory approvals, and provider relationships while the digital presence remains deliberately minimal.

• $355M raised but website traffic is zero—proving B2B medical devices don't need DTC marketing
• 50 employees generating $26.4M in revenue = $528K per employee (exceptional efficiency)
• V-Go targets the underserved mid-market: patients who need basal-bolus therapy but can't afford pumps
• Global presence via Australia/New Zealand contacts shows international strategy
• Zero social proof (Trustpilot, reviews) because medical devices are sold through providers, not online reviews